Promeditec moves to Verizon's cloud
Promeditec has chosen Verizon Cloud to support the delivery of its AppClinical Trial solution in order to support future expansion.
Archives for March 2, 2016
Teaching old drugs new treatments
Drugs currently being used to treat psychosis or depression may be able to treat emerging viruses, according to new research led by the University of Leeds.
Cell culture market to reach nearly $19bn by 2020
The global cell culture market is expected to reach $18,630.7m by 2020, up from $11,310.9m in 2015.
CROs need to educate consumers on clinical trials
Significant education is needed in order to inform consumers about the existence of clinical trials, according to a recent report.
BioOutsource facility passes US FDA inspection
A laboratory operated by recent Sartorius Stedim Biotech (SSB) acquisition BioOutsoruce has passed a GMP inspection by the US FDA.
Colorcon opens Colombia formulation lab
Colorcon has opened a formulation laboratory in Colombia to build its presence in the fast growing South American pharmaceutical market.
Criminals can manipulate drug production if IT systems not protected says expert
Hackers trying to steal drug formulae for counterfeiters can wreak havoc says an IT expert advocating stronger security for networked pharmaceutical manufacturing facilities.
Lupin confirms Kyowa wants new generics plant in Tottori
Lupin is mulling building a manufacturing plant with capacity to make two billion tablets a year in Japan in response to growing demand for generics.
France raises concerns about heparin made by Dongying Tiandong
French regulators have raised concerns about heparin made by Chinese supplier Dongying Tiandong Pharmaceutical and called on the EMA to revoke its GMP certificate.
Johnson & Johnson opens incubator to accelerate early stage research
The new Houston-based facility will support early stage research for several start-up companies.